All Articles

Stem's move to add CEO Arun Narayanan to its board is more than a title change; it's a strategic gambit to accelerate its software-first future.

As Star Group preps its year-end report, the results will offer key insights into winter heating costs and the company's strategy for a changing world.

A new report reveals retirees with guaranteed income are 30% more secure. Is this the key to solving the retirement crisis and ending financial fear?

New data shows a non-invasive light-and-sound therapy may boost brain resilience and slow Alzheimer's, positioning it as a disruptive force in the market.

Beyond the press release, a deep dive into how the Averna-Spherea consolidation is set to redefine quality engineering for mission-critical industries.

Voltus's new program pays businesses to cut energy when the grid is dirtiest, creating a novel marketplace where corporate climate goals fund new revenue.

Beyond the price surge, a deeper shift is underway. Discover how institutional adoption and artificial intelligence are fundamentally reshaping the crypto landscape.

Garrett Motion's $250M share repurchase signals deep financial confidence, but the real story is how it balances shareholder returns with a bold pivot to EV tech.

A struggling shipping firm bets its future on a $120M AI and blockchain venture. Is this a savvy pivot or a desperate move to abandon a sinking ship?

A landmark study reveals only 13% of high-risk heart patients achieve optimal cholesterol control, exposing deep systemic failures and inequities in care.

A new partnership aims to merge AI credit scoring with blockchain to tokenize auto loans, targeting a massive traditional finance market for disruption.

bioAffinity's sputum test provides clarity for ambiguous lung cancer screenings, presenting a powerful economic case for investors and healthcare providers.

A tiny share sale by investment giant Rathbones reveals subtle strategies and institutional chess moves in the high-stakes takeover battle for Unite Group.

A groundbreaking partnership is using AI to save hundreds of lives and slash operational delays, offering a powerful blueprint for data-driven healthcare.

A novel class of precision therapy enters human trials, offering a new line of defense for patients with stubborn neuroendocrine tumors and other cancers.

A novel laser treatment for glaucoma is now in human trials, promising to lower eye pressure without a single cut. This could change millions of lives.

Syllable AI's debut on the Microsoft Marketplace unlocks secure, scalable agentic AI, signaling a major shift in how businesses automate customer service.

With its lead cancer therapy on a fast track, March Biosciences taps a veteran dealmaker, signaling a strategic shift from clinical development to market play.

A tiny OTC firm lands a $6M commitment to fuel AI's voracious energy needs. Is this a visionary pivot or a high-risk gamble on the future of compute?

Sprinklr beat Q3 estimates with impressive profitability, but slowing subscription growth raises questions about its long-term strategy and transformation.